Ei Gains Exclusive World-Wide License for Sphingolipids

Charlotte, NC-based Ei, A Pharmaceutical SolutionWorks, has signed agreements with European-based professors and technologists for the exclusive worldwide license of a novel class of sphingolipids. Sphingolipids are found in the extracellular spaces of the stratum corneum, where they play a critical role in strengthening the barrier function of the skin, promoting moisture retention and increasing elasticity of the skin, according to the company.

The specific technology consists of a novel lamellar lipid topically delivered through a custom formulation system. In preliminary clinical studies, the technology has demonstrated significantly better barrier function with substantial improvement in moisture retention when compared to commercially available sphingolipid compounds. As part of this exclusive licensing arrangement, Ei has been granted options on several related technologies in various stages of development.

More info: www.eisolutionworks.com